Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

This is a single center, randomized, controlled, within-subject comparison, multiple dose study to determine the irritation potential of M518101 on normal skin under occlusive patch condition. The study drug will be applied for 21 days under occlusive patch condition. The irritation potential of M518101 will be compared with positive, negative control and M518101 vehicle. The study duration is 21days and there will be at least 23 visits to study center including screening visit.

Key facts

Study ID
NCT02227069
Run by
Maruho North America Inc.
People needed
30
Starts
2014-09-01
Expected to finish
2015-03-01
Last updated by the study team
2015-03-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.